Loading...
Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis
Dysregulation of histone methyltransferase enhancer of zeste homolog 2 (EZH2) has been implicated in the pathogenesis of many cancers. However, the role of EZH2 in peritoneal fibrosis remains unknown. We investigated EZH2 expression in peritoneal dialysis (PD) patients and assessed its role in perit...
Na minha lista:
| Udgivet i: | J Pathol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7481741/ https://ncbi.nlm.nih.gov/pubmed/31579944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/path.5352 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|